Press releaseBusiness Wire
Compass Pathways
CMPS · NASDAQ
$11.90+$0.79 (+7.11%)TodayMarket closed ·
Prev close $11.11
Latest news
- News
Compass Pathways Reports Q2 2026 Results: Full Earnings Call Transcript
- Press releaseBusiness Wire
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Press releaseBusiness Wire
Compass Pathways Appoints Kelley Boucher as Chief People Officer
- Press releaseBusiness Wire
Compass Pathways to Participate in TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit on September 23, 2026
- Press releaseBusiness Wire
Compass Pathways Launches ‘Change the Tune in TRD’ in the U.S. to Advance HCP Understanding of Treatment-Resistant Depression at Psych Congress 2026
- Press releaseBusiness Wire
Strata Mental Health Solutions Awarded U.S. Healthcare Provider Training Grant from Compass Pathways to Develop Provider Training for COMP360
- Press releasePRNewswire
Fluence Selected by Compass Pathways to Develop Post-Approval COMP360 Provider Training
- Press releaseBusiness Wire
Compass Pathways Announces U.S. Grant Program Recipients for the Development of Post-Approval COMP360 Provider Training
- Press releaseBusiness Wire
Compass Pathways to Participate in Investor Conferences the Week of September 14th
- NewsVandana Singh
Compass Pathways’ Psilocybin Treatment Shows Lasting Benefits in Treatment-Resistant Depression
- Press releaseBusiness Wire
Compass Pathways’ New 52-Week Topline Open-Label Data from Phase 3 COMP005 Trial Demonstrates Additional Benefit from Another COMP360 Dose in Part C Extending Durability Out to 1 Year
- News
'FDA’s Acting Drug, Vaccine Regulators Tapped for Permanent Roles'- Bloomberg
- Press releaseBusiness Wire
Compass Pathways to Debut U.S. HCP Education Campaign and Present New HEOR Data at Psych Congress 2026
- Press releaseBusiness Wire
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Press releaseBusiness Wire
Compass Pathways Recognized as a 2026 Fierce 50 Breakthrough Honoree
- Press releaseBusiness Wire
Compass Pathways to Participate in 2026 Cantor Global Healthcare Conference on September 9, 2026
- Press releaseBusiness Wire
Compass Pathways to Participate in Canaccord Genuity's 46th Annual Growth Conference on August 12, 2026
- Press releaseBusiness Wire
Compass Pathways Working with U.S. Department of Veterans Affairs for Investigational Study of Psilocybin
- Press releaseBusiness Wire
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Press releaseGlobe Newswire
A CEO With a Proven Track Record of Success in Growing and Scaling Biopharmaceutical Companies Just Appointed CEO at a Clinical-Stage Biotech, Months Before Its Pivotal Phase 3 Readout
- Press releaseBusiness Wire
Compass Pathways Announces Second Quarter and First Half 2026 Financial Results and Business Highlights
- Press releaseBusiness Wire
Compass Pathways to Announce Second Quarter and First Half 2026 Financial Results on August 5, 2026
- NewsKaustubh Bagalkote
Why Is Robinhood Stock Falling on Thursday?
- NewsChandrima Sanyal
Cathie Wood Swaps Robinhood for SpaceX, Archer—Did ARK Pivot Back to Moonshot Innovation?
- Press releasePRNewswire
A Depression Drug Just Cleared a Key Hurdle Early, and the Market for New Mental Health Treatments Keeps Widening
- Press releasePRNewswire
Billions Flow Into Next-Generation Depression Treatments as Pharma Innovation Accelerates
- NewsVandana Singh
Why Is Neuronetics Stock Soaring Monday?
- Press releasePRNewswire
Big Pharma Just Paid Up to $3.8 Billion for Psychedelic Medicine, and the Rest of the Sector Is Being Repriced in Real Time
- NewsVandana Singh
Why Is GH Research Stock Trading Higher on Thursday?
- NewsAvi Kapoor
Why JB Hunt Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
- NewsAvi Kapoor
Why LiveRamp Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket
- News
Transcript: Compass Pathways Q1 2026 Earnings Conference Call
- NewsDylan Berman
Compass Pathways Reports Strong Q1 Results, Shares Surge
- News
Earnings Scheduled For May 13, 2026
- News
12 Health Care Stocks Moving In Monday's Intraday Session
- NewsAvi Kapoor
Wingstop Posts Upbeat Q4 Earnings, Joins Caesars Entertainment, Garmin, Sabre And Other Big Stocks Moving Higher On Wednesday
- NewsAvi Kapoor
Palo Alto, Fiverr International, Axcelis Technologies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.